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We have identified a novel mutation within the linker
L12 region of keratin 5 (K5) in a family with the Ko¨bner
variant of epidermolysis bullosa simplex. The pattern of
inheritance of the disorder in this family is consistent
with an autosomal dominant mode of transmission.
Affected individuals develop extensive and generalized
blistering at birth or early infancy but in later years
clinical manifestations are largely confined to palmo-
plantar surfaces. Direct sequencing of polymerase chain
reaction products revealed a T to C transition within
codon 323 of K5 in affected individuals, resulting in a
valine to alanine substitution of the seventh residue within
the L12 linker domain. This mutation was not observed
in unaffected family members or in 100 K5 alleles of
unrelated individuals with normal skin. The other critical
Several genetic disorders of the integument, characterized bycell cytolysis as a result of physical trauma, have beenshown to be associated with keratin mutations (reviewed inRothnagel, 1996). Electronmicroscopy of these disordersinvariably reveals abnormal keratin filaments with tonofila-
ment clumping and a collapsed keratin filament cytoskeleton, often
with a perinuclear distribution (Anton-Lamprecht, 1994). Keratins are
intermediate filament proteins that are expressed as coordinate pairs of
type I and type II subunits in a tissue and differentiation-state specific
manner (Steinert, 1993). Keratins have a conserved domain structure,
which is common to all intermediate filament proteins, consisting of
a central α-helical rod domain flanked by nonhelical N- and C-
terminal domains (Steinert and Roop, 1988). The α-helical domain is
interrupted by three nonhelical linker peptides denoted as L1, L12,
and L2, which separate the rod domain into the 1A, 1B, 2A, and 2B
helical segments. Mature keratin filaments are assembled from coiled-
coil heterodimers, each consisting of a type I (keratins K9–K21) and a
type II (K1–K8) subunit held together through interactions between
the α-helical domains (Hatzfeld and Weber, 1990; Steinert, 1990).
The dimers in turn polymerise both laterally and longitudinally to
form the 10 nm filaments. Mutations in keratin subunits generally do
not interfere with dimer formation or polymerization but instead act
dominantly to reduce the tensile strength of the mature filament.
Epidermolysis bullosa simplex (EBS) is a rare genetic disease charac-
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regions of K5 and K14 were unremarkable in this family
except for common polymorphisms that have been previ-
ously described. The valine at position 7 of the L12
domain is absolutely conserved in all type II keratins,
and in other intermediate filament subunits as well,
which suggests that this residue makes an important
contribution to filament integrity. Secondary structure
analysis revealed that alanine at this position markedly
reduces both the hydrophobicity and the b-sheet nature
of the L12 domain. This is the first report of a mutation
at this position in an intermediate filament subunit and
reinforces the importance of this region to filament
biology. Key words: disease/genetics/intermediate filaments.
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terized by blistering of the skin and internal epithelia (Fine et al, 1991;
Epstein, 1992). Blistering occurs as a result of cytolysis of basal layer
keratinocytes that have a reduced capacity to withstand environmental
insults such as mild mechanical trauma, increased temperature, sweating,
or stress. The disorder is usually autosomal dominant but some recessive
cases have been noted (Fine et al, 1991). Three clinical subtypes of
EBS have been defined on the basis of phenotypic severity; Dowling–
Meara, Ko¨bner, and Weber–Cockayne (Fine et al, 1991). The Dowling–
Meara type represents the severest form of the disease, the Ko¨bner
type an intermediate form, and the Weber–Cockayne variant the
mildest, with blisters limited to surfaces that receive the most insults,
such as the palms and soles. Other EBS subtypes have been defined
on the basis of associated pathologies such as EBS with mottled
pigmentation and EBS with muscular distrophy (Fine et al, 1991).
Early ultrastructural analyses first implicated the keratins as the site of
the defect in EBS (Anton-Lamprecht, 1983), and later immunoelectron
microscopy revealed that the aggregated filaments were composed of
the basal cell keratins K5 and K14 (Ishida-Yamamoto et al, 1991).
Experimental studies demonstrated that mutant forms of K14 could
induce filament clumping, similar to that observed in EBS patients,
when expressed in cultured cells or in the epidermis of transgenic mice
(Albers and Fuchs, 1989; Vassar et al, 1991). Gene linkage data showed
that EBS mapped to the keratin gene clusters on chromosomes 12 and
17 and mutations were subsequently identified in K5 and K14 in affected
individuals (Epstein, 1992). Both patient studies and experimental data
have shown a striking correlation between the position of the mutation
and the severity of the clinical phenotype (Letai et al, 1993; Rothnagel,
1996), with mutations in the highly conserved motifs at the ends of
the rod domains producing severe blistering as seen in Dowling–Meara
patients, in contrast to mutations within the H1 or L12 regions, which
are usually associated with the milder forms of disease such as the
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Weber–Cockayne variant of EBS. Here we report a family diagnosed
with the more severe Ko¨bner form of EBS (EBS-K) and demonstrate
the presence of a novel mutation in the L12 region of K5 in affected
individuals.
MATERIALS AND METHODS
Polymerase chain reaction and DNA sequencing Genomic DNA was
extracted and purified from whole blood using the QIAamp blood kit according
to the manufacturer’s instructions (QIAGEN, Hilden, Germany). The L12
region of K5 was amplified from genomic DNA using specific oligonuleotides
(59-CACAACACAGAACCAGATGAC-39 and 59-CATTCTTAGTGTCGT-
CATGGC-39) corresponding to bp 101–121 of intron 4 and to 59–79 of intron
5 of the sequences determined by Stephens et al (1997). The sequencing primer
(59-TGACCGACTCCAAATCTC-39) corresponds to bp 118–135 of the
published intron 4 sequence (Stephens et al, 1997). The polymerase chain
reaction reactions were preheated (95°C, 5 min), 2.5 units of Taq polymerase
added, and cycled 35 times (94°C, 45 s; 56°C, 30 s; 72°C, 45 s) with a final
extension at 72°C for 10 min. Polymerase chain reaction products were purified
using QIAEX II (QIAGEN) and directly sequenced using the Thermo Sequenase
dye terminator cycle sequencing system (Amersham Life Science, Cleveland,
OH). Sequencing products were analyzed on an ABI Prism 377 automated
sequencer (Applied Biosystems, Foster City, CA).
Mutation analysis by restriction enzyme digestion The L12 region of
K5 was amplified using the oligonucleotides and polymerase chain reaction
conditions listed above and the purified DNA digested with MspA1 I (New
England Biolabs, Beverly, MA). The digest products were separated on a 2%
agarose TAE gel (Sambrook et al, 1989) in the presence of ethidium bromide
and visualized by UV light.
RESULTS
Clinical description of the EBS family We studied a multigener-
ation family in which a diagnosis of EBS-K was made on the basis of
a clinical history of generalized blistering with minimal oral involvement
developing at birth or early in infancy and associated with a histopatho-
logy of basal layer degeneration. The index case, an 18 y old male,
also suffered from microcytosis (cause not identified) and cystic
acne. His treatment included oral retinoids (Roaccutane), which was
complicated by increasing epidermal fragility requiring dosages to be
maintained below 0.5 mg per kg per d. There was significant variation
in the severity of symptoms exhibited by affected family members.
Although the proband and his mother still suffer from generalized
blistering, other family members reported that blistering rarely occurred
outside of palmoplantar surfaces. All reported that blistering was more
severe and generalized during childhood.
Identification of a valine to alanine substitution in the L12
region of K5 We sequenced the coding regions of both K5 and
K14 of affected and unaffected family members. This analysis revealed
a number of base changes from the published sequences that were
present in both affected and unaffected individuals and represent allelic
differences in the population (Wanner et al, 1993); however, we noted
a single base substitution (GTG→GCG) in codon 323 of K5 that was
only present in affected individuals (Fig 1). The T to C transition
results in the expression of an alanine residue instead of valine at
position 7 (V7A) of the L12 domain. The base change also creates a
restriction enzyme site recognized by MspA1 I and this was exploited
to rapidly screen for the mutation in the EBS-K family (Fig 2) and in
the normal population (data not shown). Notably, this change was not
observed in unaffected family members or in the DNA from 50
unrelated and unaffected control individuals.
The valine to alanine substitution produces a significant struc-
tural change in L12 The affected valine residue at position 7 of the
K5 L12 domain occurs at the beginning of a conserved motif of
alternating apolar-nonpolar residues (VXLXMD in type II keratins)
that has been recognized in all L12 sequences and suggests a β-type
structure for this region (North et al, 1994). The V7 residue is absolutely
conserved in all type II keratins and in many other intermediate
filament proteins as well (Fig 3). The equivalent residue in the type I
keratins is also valine or another apolar residue such as leucine (Conway
and Parry, 1988). The strict conservation of valine at this site suggests
Figure 1. Sequence analysis of the L12 domain of K5 in EBS-K patients
and unaffected family members. (a) Sequence of the normal K5 alleles
obtained from an unaffected family member. (b) Direct genome sequencing of
the proband (individual III.2 in Fig 2) who is heterozygous for the mutant
allele. The affected individual contains a T to C mutation (indicated by the
arrow) in codon 323, resulting in the expression of alanine at position 7 of
the L12 domain. The sequence shown begins at the first codon of the L12
domain.
Figure 2. Restriction enzyme analysis of codon 323 showing
cosegregation of the mutation with affected individuals. The L12 region
of K5 was amplified and the 280 bp product digested with Msp A1 I. The T
to C transition identified in the proband creates a Msp A1 I site in the mutant
allele and results in 197 bp and 83 bp fragments after digestion. Wild-type
alleles remain uncut. Solid symbols denote affected individuals, open symbols
unaffected individuals; males are represented by squares and females by circles.
The arrow indicates the proband (individual III.2).
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Figure 3. Sequence comparison of the L12 linker peptide showing
conservation of the valine residue at position 7. The delineation of the
L12 region is as determined by Conway and Parry (1988). EBSmut indicates
the disease-associated mutations found in this study (V7A) and in other studies
(Rugg et al, 1993; Chan et al, 1994; Matsuki et al, 1995). The SwissProt
accession numbers are: K5-P13647; K1-P04264; K2e-P35908; K2p-Q01546;
K3-P12035; K4-P19013; K6a-P02538; K7-P08729; K8-P05786; XK8 Xenopus
laevis-P04266; FK8 Carassius auratus-P18520; Wool(7c) Ovis aries-P15241;
Vimentin-P08670; Desmin-P17661; GFAP-P14136; Hagfishγ polymer-
Q90502.
Figure 4. Secondary structure analysis of the L12 linker peptide. The
Chou and Fasman algorithm of the peptide analysis tool (PEPPLOT) of ANGIS
(http://www.angis.su.oz.au/) was used to calculate the affect of the alanine
substitution at position seven. The graphs show the propensity for α-helix (red
curve) and β-sheet (blue curve) formation for the normal L12 sequence (a) and
the mutant L12 sequence (b). Both curves are the average of a residue-specific
attribute over a window of four residues. The threshold value for the
continuation of a given structure is arbitrarily set at 1.0.
that any change is likely to be deleterious although a priori, the alanine
substitution at this position might be thought of as semiconservative.
We therefore performed secondary structure analyses in an attempt to
gauge the effect of the mutation on the L12 domain. A hydropathy
plot revealed a marked reduction in hydrophobicity in the L12 peptide
when alanine is substituted for valine at position 7 (data not shown)
concomitant with a reduction in the β-sheet nature of this domain
(Fig 4). These results suggest a large departure from the normal
secondary structure of L12 in the V7A mutant.
DISCUSSION
The L12 linker peptide demarcates the end of the 1B and the beginning
of the 2A α-helical segments and is found in all intermediate filament
proteins, but its contribution to filament assembly and/or function has
not been unequivocally determined. Current filament assembly models
predict that the L12 region is in close proximity to the L2 and H2
regions in the staggered alignment of coil-coiled dimers, or with the
L12 region of a neighboring pair of subunits in the nonstaggered
antiparallel alignment (Steinert, 1993). In the antiparallel alignment,
the four L12 regions are in a position to contribute to tetramer stability
and in turn to filament stability through hydrophobic interactions with
one another. Prior to this study, four other mutations in the L12 region
of K5 had been reported and interestingly, all occur in the C-terminal
half of the peptide (Fig 3) where they are predicted to promote α-
helical formation at the expense of the normal β-sheet structure (Rugg
et al, 1993; Chan et al, 1994; Matsuki et al, 1995). It has been postulated
that these structural changes would result in a more rigid molecule
with less resistance to torsional stress (McLean and Lane, 1995). These
mutations may also impair the normal packing of dimers in the
filament resulting in diminished interactions between residues critical
for maintaining tensile strength. In vitro modeling of K5 L12 mutations
(M11T and N13K) have shown that these substitutions tend to cause
filament unravelling and result in loosely packed, shortened filaments
with an apparent increase in diameter (Chan et al, 1994). These authors
concluded that the L12 region plays a prominent role in stabilizing
lateral associations between heterodimers. Given that the V7A mutation
found in this study also has a marked affect on the secondary structure
of L12, it is likewise postulated to interfere with lateral interactions,
leading to a weakening of the keratin filament network and the
subsequent clinical manifestations in these patients. Notwithstanding
the predicted changes in secondary structure, the substitution of alanine
for valine also produces a significant side chain alteration at this
position. The absence of the extended branched side chain of valine
could result in the loss of critical interactions with residues of proximal
subunits and a subsequent reduction in filament stability (Alber, 1989;
Zhu et al, 1993).
It should be noted that although some of the patients in this study
display symptoms consistent with the Ko¨bner form of EBS, a diagnosis
of EBS–Weber–Cockayne may be equally appropriate for other mem-
bers of this family, particularly older individuals. By comparison, the
other K5 L12 mutations have all been identified in patients with the
classical EBS–Weber–Cockayne symptoms of mild blistering limited
to palmoplantar epidermis (Rugg et al, 1993; Chan et al, 1994; Matsuki
et al, 1995). This suggests that the V7A mutation has a more profound
affect on filament function than the other K5 L12 mutations, and
further underscores the importance of this valine residue to the biology
of the L12 domain. Similarly, both K14 L12 mutations (V8M and
M10R) were also associated with more severe symptoms (Rugg et al,
1993; Humphries et al, 1993), with the M10R substitution identified
in a family diagnosed with EBS-K (Humphries et al, 1993). Taken
together these studies provide an indication of the relative contribution
of each of these L12 residues to filament stability.
In this study we have identified a novel mutation within the L12
region of K5 that is associated with a clinical phenotype. Although we
have no functional data proving that this mutation is pathogenic, both
genetic evidence and structural analysis data strongly suggest that it is.
This mutation was only observed in individuals with clinical symptoms
and not in unaffected family members. Moreover, the mutation was
not observed in any of the 100 normal K5 alleles that were screened
as part of this study, nor have there been any reports of benign
polymorphisms occurring at this site. The V7A mutation found in this
EBS-K family is predicted to markedly alter the secondary structure
of the L12 domain, resulting in a weakening of the cytoskeleton of
basal layer keratinocytes. The identification of this substitution adds to
the catalog of disease-associated mutations involving residues of the
K5 and K14 L12 linker domains.
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